产品详情
靶点信息
JAK2 | ||||
<5 μM |
In vitro | DMSO | 89 mg/mL (191.58 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 24 mg/mL (51.66 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.53 mL | 107.63 mL | 215.26 mL |
0.5 mM | 4.31 mL | 21.53 mL | 43.05 mL |
1 mM | 2.15 mL | 10.76 mL | 21.53 mL |
5 mM | 0.43 mL | 2.15 mL | 4.31 mL |
*The above data is based on the productmolecular weight 464.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A15911 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 464.55 |
Formula | C28H32O6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1226895-15-3 |
Synonyms | FLLL-32, FLLL 32 |
SMILES | O=C(C1(C(/C=C/C2=CC=C(OC)C(OC)=C2)=O)CCCCC1)/C=C/C3=CC=C(OC)C(OC)=C3 |
产品标签
Product Questions
Product Questions
R406 besylate
R406 besylate是一种口服酪氨酸激酶抑制剂,IC50为41 nM。对Syk抑制作用强,但是不抑制Lyn,对Flt3的作用比对Syk…
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。
AC220 (Quizartinib)
AC220 (Quizartinib)是一种有效的选择性FLT3抑制剂,对于MC4-11和A375,IC50分别为0.56±0.3 nM和> 10 mM。
TG-101348 (Fedratinib, SAR302503)
TG-101348 (Fedratinib,SAR302503)是Janus相关激酶2的口服生物利用型,ATP竞争性和选择性抑制剂,在无细胞试验中IC5…
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂,在无细胞试验中的IC50为7 nM,选择性是Pim2和Pim3的50倍和10…